The fundamentals don't look horrible, but there are a couple red flags for me. First, the institutional ownership is a little over 83%. This can lead to a lot of volatility if the business does not to perform to expectations. Second, it's currently trading at its 52-week high. There is a level of support in the $31-32 range, but unless you are planning on investing in this long-term, now might not be the best time to enter if you're primarily looking for growth.
Medical device companies are tricky to valuate because there is a ton of competition and a lot of the services/goods they offer often only fill niche market segments. A company that is not diversified is exposed to significant risk. Because patents expire at some point, the company must constantly innovate to remain relevant (which is true for any company, really) - this is the risk that you take with less-established firms.
Probably my biggest concern with a company like this is their intangible assets (Goodwill, IP, etc)
account for nearly 30% of total assets. Intangible assets make it very difficult to valuate a firm's true value without dedicating a lot of time to research.
The best advice I can give you is that unless you are willing sit down and figure out discounted cash flows, WACC, discount rates, etc it is in your best interest to stick with index funds. Typically I only invest in individual stocks if a certain sector is underperforming (energy is the most relevant recent example). Even then, comparing the performance of companies to their peers is tricky due to accounting/financial reporting procedures that are unique to the individual firms. It really takes someone that has the experience of the sectors they're analyzing to read between the lines and determine whether a company is undervalued or not.
Only about 3.5% of my total portfolio (not including my company's ESPP) is dedicated to individual stocks, but I am more concerned about my long-term financial future than making a quick buck on stocks in the short-term. I could be dead wrong on my quick review of their financials, and the stock could soar another 2000% by next year, but I prefer the unexciting, slow and steady growth of index funds.